Prevision Medicine AG
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Prevision Medicine AG - overview
Established
2024
Location
Schlieren, -, Switzerland
Primary Industry
Healthcare Specialists
About
Founded in 2024 and based in Schlieren, Switzerland, Prevision Medicine AG provides ex vivo drug testing services through its PrevisionOne platform, which analyzes patients’ living cancer cells against drugs and drug combinations and delivers clinical reports to help oncologists select treatment options.
Current Investors
ACE & Company, Swiss ICT Investor Club, GoHub Ventures
Primary Industry
Healthcare Specialists
Sub Industries
Healthcare IT, Oncology/Cancer Treatment
Website
www.previsionmedicine.com/
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Prevision Medicine AG - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Seed | Completed | Prevision Medicine AG | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.